BOSTON--(BUSINESS WIRE)--Leerink Capital Partners (“LCP”), a multi-strategy healthcare-focused principal investment business, announced today that Karl Beinkampen, CFA will join the firm in June as President, responsible for all aspects of LCP’s business and activities. Mr. Beinkampen’s hiring follows successful fund closings in two of LCP’s private fund families.
Mr. Beinkampen joins Leerink Capital Partners from Wilshire Private Markets (“WPM”), a division of Wilshire Associates, where he was President and Chief Investment Officer, responsible for leading its global private markets business. From 2010 to 2018, Mr. Beinkampen served on WPM’s Business Committee and as Chair of its Investment Committee. He also served as a member of the Wilshire Associates Board of Directors from 2014 to 2018. Prior to Wilshire, Mr. Beinkampen spent 15 years at Morgan Stanley, where he was most recently a Managing Director of the firm's Alternative Investment Partners division. He began working with LBO sponsors in 1995 within Morgan Stanley’s Investment Banking division, leading equity, fixed income and acquisition finance transactions, and joined Morgan Stanley’s Private Equity Fund of Funds business shortly after its inception in 2000. Earlier in his career, Mr. Beinkampen worked in mergers and acquisitions with Scully Brothers & Foss, as well as Kidder Peabody & Co.
Mr. Beinkampen is a cum laude graduate of Princeton University with a degree in Economics and received his Master of Business Administration from the University of Pennsylvania's Wharton School with a dual degree in Finance and Operations Management. He is a CFA charterholder and has nearly three decades of experience in the investment management industry.
“Karl is a talented and proven executive who will bring significant expertise and insight to Leerink Capital Partners,” said Jeff Leerink, Chairman and CEO of Leerink Partners. “We look forward to Karl leading Leerink Capital Partners as we accelerate the growth of this important initiative.”
“As successful private markets investment strategies are increasingly differentiated by deep sector expertise, Leerink Capital Partners is uniquely positioned to provide compelling private capital investment opportunities in healthcare,” said Mr. Beinkampen. “I look forward to working with the LCP team to expand our current investment platform and augment our client service and capital formation capabilities.”
About Leerink Capital Partners
Leerink Capital Partners LLC was formed in 2013 to build and lead a multi-strategy, healthcare-focused principal investment business with a dedicated team experienced in originating, structuring and managing healthcare investments. LCP leverages the healthcare expertise, proprietary analytics and insights, and deep industry relationships of its affiliate, Leerink Partners, a leading investment bank specializing in healthcare. For more information, please visit: www.leerinkcapital.com.
About Leerink Partners
Leerink Partners LLC is a leading investment bank, specializing in healthcare. Our knowledge, experience and focus enable us to help our clients define and achieve their strategic, capital markets and investment objectives. We partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare. Leerink Partners LLC is a member of FINRA/SIPC. For more information, please visit: www.leerink.com.